Dasatinib for a child with Philadelphia chromosome-positive acute lymphoblastic leukemia and persistently elevated minimal residual disease during imatinib therapy.

Wu, K H; Wu, H P; Weng, T; Peng, C T; Chao, Y H

Wu, K H; Wu, H P; Weng, T; Peng, C T; Chao, Y H.

Afiliación

Wu KH; School of Chinese Medicine, China Medical University, Taichung, Taiwan; ; Department of Pediatrics, Children's Hospital, China Medical University, Taichung, Taiwan;
Wu HP; Department of Pediatrics, Buddhist Tzu-Chi General Hospital, Taichung Branch, Taichung, Taiwan;
Weng T; Department of Pediatrics, Children's Hospital, China Medical University, Taichung, Taiwan;
Peng CT; School of Chinese Medicine, China Medical University, Taichung, Taiwan; ; Department of Pediatrics, Children's Hospital, China Medical University, Taichung, Taiwan; ; Department of Biotechnology and Bioinformatics, Asia University, Taichung, Taiwan;
Chao YH; Department of Pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan; ; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.

Curr Oncol ; 22(4): 303-6, 2015 Aug.

Article en En | MEDLINE | ID: mdl-26300669

Palabras clave

Dasatinib; Philadelphia chromosome; acute lymphoblastic leukemia; children; complete molecular remission

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Curr Oncol Año: 2015 Tipo del documento: Article Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google